GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » Cash Flow from Others

Optimind Pharma (XCNQ:OMND) Cash Flow from Others : C$1.90 Mil (TTM As of Nov. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma Cash Flow from Others?

Optimind Pharma's cash flow from others for the three months ended in Nov. 2023 was C$0.01 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Nov. 2023 was C$1.90 Mil.


Optimind Pharma Cash Flow from Others Historical Data

The historical data trend for Optimind Pharma's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma Cash Flow from Others Chart

Optimind Pharma Annual Data
Trend Feb22 Feb23
Cash Flow from Others
- 0.31

Optimind Pharma Quarterly Data
Jun21 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23
Cash Flow from Others Get a 7-Day Free Trial 0.02 1.83 0.03 0.03 0.01

Optimind Pharma Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$1.90 Mil.

Optimind Pharma Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimind Pharma (XCNQ:OMND) Business Description

Traded in Other Exchanges
N/A
Address
3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8
Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines